Clinical Trial Update: A Clinical Study of Herombopag in Tumors-associated Thrombocytopenia [Phase 2]

View source ↗

Summary

Phase 2 clinical study of Herombopag in tumor therapy-related thrombocytopenia is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tumor Therapy-related Thrombocytopenia

Drugs mentioned

• Herombopag (herombopag)

Snippet

Sponsor: The First Affiliated Hospital of Zhengzhou University | Conditions: Tumor Therapy-related Thrombocytopenia | Phase 2 | Status: UNKNOWN